Catalunya Central Health region, Spain  

COnV-ert study, convalescent plasma to stop COVID-19

Early administration of convalescent plasma in people over 50 years of age with mild to moderate COVID-19 disease may slow disease progression and decrease the severity of symptoms.

Institut Català de la Salut, Spain  

E-speranza-COVID19 Project

This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.


ANTICOV Study: COVID-19 in Africa

Collaborate with ANTICOV study to treat COVID-19 in Africa.


Solidarity Trial: COVID-19 Treatments

Solidarity is an international clinical trial to evaluate the effect of a number of drugs for the treatment of COVID-19.


COVIDAir: A New Technology To Detect COVID-19 Patients

This study aims to determine the validity of a new method to detect COVID-19 by characterising molecules in exhaled air.

Assistance Publique des Hopitaux de Paris, France  

Convalescent plasma therapy and COVID-19

Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.

Hospital Infantil Universitario Niño Jesús, Spain  


This clinical trial aims to explore the efficacy of allogeneic mesenchymal cells from umbilical cord tissue in patients with severe COVID-19 lung disease.

Cedars-Sinai Medical Center, Los Angeles  

Progesterone for the Treatment of COVID-19

Can sex hormones help men survive COVID-19? This study assesses the safety and efficacy of progesterone for the treatment of COVID-19 in hospitalized men.

Hospital La Paz et al., Spain  

PanCOVID19: Evaluating Pharmacological Treatments

Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.


University of Rochester, New York  

AstraZeneca Study of COVID-19 Vaccine Candidate AZD1222

Clinical trial designed to determine if the vaccine candidate, AZD1222, can prevent symptomatic COVID-19.

Georges-Pompidou European Hospital, France  


The STROMA-CoV trial aims to treat patients with severe acute respiratory syndrome due to SARS-CoV-2 by intravenous administration of umbilical cord mesenchymal stromal cells.

Catalonia, Spain  

Plants Against COVID-19

The study aims to identify plants based on traditional knowledge that can reduce or eliminate symptoms and the length of illness in non-hospitalised patients with COVID-19.